Cargando…

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease

Detalles Bibliográficos
Autores principales:	Hung, Szu‐Chun, Kuo, Ko‐Lin, Wu, Chih‐Cheng, Tarng, Der‐Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523780/ https://www.ncbi.nlm.nih.gov/pubmed/28174171 http://dx.doi.org/10.1161/JAHA.116.005022

Ejemplares similares

Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
por: Wu, Chih-Cheng, et al.
Publicado: (2017)

Indoxyl sulfate impairs valsartan-induced neovascularization()
por: Kuo, Ko-Lin, et al.
Publicado: (2020)

The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease
por: Wu, Chih-Jen, et al.
Publicado: (2017)

Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
por: Liu, Wen-Chih, et al.
Publicado: (2018)

High Uric Acid Ameliorates Indoxyl Sulfate-Induced Endothelial Dysfunction and Is Associated with Lower Mortality among Hemodialysis Patients
por: Hsu, Wei-Liang, et al.
Publicado: (2017)

Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease
por: Cheng, Tong-Hong, et al.
Publicado: (2020)

Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
por: Lu, Chien-Lin, et al.
Publicado: (2021)

Correction: The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease
por: Wu, Chih-Jen, et al.
Publicado: (2019)

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies
por: Hung, Szu-Chun, et al.
Publicado: (2015)

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease
por: Kuo, Ko-Lin, et al.
Publicado: (2017)

The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients
por: Wu, Ping-Hsun, et al.
Publicado: (2021)

Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients
por: Lin, Ting-Yun, et al.
Publicado: (2020)

The Effects of Indoxyl Sulfate and Oxidative Stress on the Severity of Peripheral Nerve Dysfunction in Patients with Chronic Kidney Diseases
por: Lai, Yun-Ru, et al.
Publicado: (2022)

Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis
por: Kuo, Ko-Lin, et al.
Publicado: (2015)

Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease
por: Chen, Cheng-Hsu, et al.
Publicado: (2022)

Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis
por: Shyu, Jia-Fwu, et al.
Publicado: (2021)

Association between Serum Indoxyl Sulfate Levels and Endothelial Function in Non-Dialysis Chronic Kidney Disease
por: Wang, Chih-Hsien, et al.
Publicado: (2019)

Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2015)

Assessment of ELISA-based method for the routine examination of serum indoxyl sulfate in patients with chronic kidney disease
por: Duan, Shuangdi, et al.
Publicado: (2022)

Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
por: Chen, Yu-Hsin, et al.
Publicado: (2015)

Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children
por: Holle, Johannes, et al.
Publicado: (2020)

Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2012)

Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013)

Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure
por: Lin, Cheng-Jui, et al.
Publicado: (2015)

The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018)

p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
por: Hyun, Hye Sun, et al.
Publicado: (2013)

Association between serum indoxyl sulfate levels with carotid-femoral pulse wave velocity in patients with chronic kidney disease
por: Wang, Sheng-Chao, et al.
Publicado: (2021)

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
por: Huang, Jeng-Yi, et al.
Publicado: (2016)

The association of indoxyl sulfate with fibroblast growth factor‐23 in cats with chronic kidney disease
por: Liao, Yu‐Lun, et al.
Publicado: (2019)

Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease
por: Wang, Li, et al.
Publicado: (2020)

Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
por: Kamiński, Tomasz W., et al.
Publicado: (2017)

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
por: Wu, I-Wen, et al.
Publicado: (2011)

Inverted U-Curve Association between Serum Indoxyl Sulfate Levels and Cardiovascular Events in Patients on Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2021)

Indoxyl Sulfate, a Uremic Endotheliotoxin
por: Lano, Guillaume, et al.
Publicado: (2020)

Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure
por: Imazu, Miki, et al.
Publicado: (2020)

DPP-4 Inhibitor Attenuates Toxic Effects of Indoxyl Sulfate on Kidney Tubular Cells
por: Wang, Wei-Jie, et al.
Publicado: (2014)

Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease
por: Sato, Emiko, et al.
Publicado: (2016)

Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease
por: Chen, Jing, et al.
Publicado: (2016)

Association Between Indoxyl Sulfate and Dialysis Initiation and Cardiac Outcomes in Chronic Kidney Disease Patients
por: Takkavatakarn, Kullaya, et al.
Publicado: (2022)

Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo
por: Tsai, Li-Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dc1pt9887u9ki4c6rbqjoio3ed